The HUS Group requests tenders for radioactive seeds for localizing breast cancer. The procurement includes the products that are described in more detail in Annex 1 Product and Price Form. The tenderer must enter the product details and offered prices in Annex 1 Product and Price Form. The procurement is divided into lots, as follows: 1. Seeds and needles separately, activity 0.1 mCi 2. Seeds and needles separately, activity 0.2 mCi 3. Seeds preloaded in the needle, activity 0.1 mCi 4. Seeds preloaded in the needle, activity 0.2 mCi The tenderers may leave a tender to one or more lots as they decide. The goal of this competitive procurement is to get products that are safe to use and serve the intended purpose. The goal is also to have good product delivery reliability and to have products available when they are needed. The subject matter of the procurement also includes additional products related to the products tendered, such as additional sizes and accessories, which are indicated in Annex 1 Product and Price Form. In addition, during the contract period, products belonging to the product groups that are the subject of the contract, may be acquired in accordance with the estimated value of the contract, also when they are not specified in the product annex (please see draft agreement). The agreement period is two (2) years. It may be extended by an option period of 1 + 1 years. The total estimated value of the procurement (VAT 0%) is approximately EUR 900 000 -1 100 000. This is an estimate and the contracting entity does not commit neither to the stated euro amounts and nor the consumption figures indicated in the invitation to tender. The final order quantities may be higher or lower than stated. The subject matter and requirements of the procurement are described in detail in the invitation to tender and its annexes.
Määräaika
Tarjousten vastaanottamisen määräaika oli 2026-03-09.
Hankinta julkaistiin 2026-02-03.
Toimittajat
Seuraavat toimittajat mainitaan hankintapäätöksissä tai muissa hankinta-asiakirjoissa:
hankintailmoitus (2026-02-03) Kohde Hankinnan laajuus
Otsikko: Radioactive seeds for localizing breast cancer
Viitenumero: HUS 365-2025
Lyhyt kuvaus:
The HUS Group requests tenders for radioactive seeds for localizing breast cancer. The procurement includes the products that are described in more detail in Annex 1 Product and Price Form. The tenderer must enter the product details and offered prices in Annex 1 Product and Price Form.
The procurement is divided into lots, as follows:
1. Seeds and needles separately, activity 0.1 mCi 2. Seeds and needles separately, activity 0.2 mCi 3. Seeds preloaded in the needle, activity 0.1 mCi 4. Seeds preloaded in the needle, activity 0.2 mCi The tenderers may leave a tender to one or more lots as they decide.
The goal of this competitive procurement is to get products that are safe to use and serve the intended purpose. The goal is also to have good product delivery reliability and to have products available when they are needed.
The subject matter of the procurement also includes additional products related to the products tendered, such as additional sizes and accessories, which are indicated in Annex 1 Product and Price Form. In addition, during the contract period, products belonging to the product groups that are the subject of the contract, may be acquired in accordance with the estimated value of the contract, also when they are not specified in the product annex (please see draft agreement).
The agreement period is two (2) years. It may be extended by an option period of 1 + 1 years.
The total estimated value of the procurement (VAT 0%) is approximately EUR 900 000 -1 100 000. This is an estimate and the contracting entity does not commit neither to the stated euro amounts and nor the consumption figures indicated in the invitation to tender. The final order quantities may be higher or lower than stated.
The subject matter and requirements of the procurement are described in detail in the invitation to tender and its annexes.
The HUS Group requests tenders for radioactive seeds for localizing breast cancer. The procurement includes the products that are described in more detail in Annex 1 Product and Price Form. The tenderer must enter the product details and offered prices in Annex 1 Product and Price Form.
The procurement is divided into lots, as follows:
1. Seeds and needles separately, activity 0.1 mCi 2. Seeds and needles separately, activity 0.2 mCi 3. Seeds preloaded in the needle, activity 0.1 mCi 4. Seeds preloaded in the needle, activity 0.2 mCi The tenderers may leave a tender to one or more lots as they decide.
The goal of this competitive procurement is to get products that are safe to use and serve the intended purpose. The goal is also to have good product delivery reliability and to have products available when they are needed.
The subject matter of the procurement also includes additional products related to the products tendered, such as additional sizes and accessories, which are indicated in Annex 1 Product and Price Form. In addition, during the contract period, products belonging to the product groups that are the subject of the contract, may be acquired in accordance with the estimated value of the contract, also when they are not specified in the product annex (please see draft agreement).
The agreement period is two (2) years. It may be extended by an option period of 1 + 1 years.
The total estimated value of the procurement (VAT 0%) is approximately EUR 900 000 -1 100 000. This is an estimate and the contracting entity does not commit neither to the stated euro amounts and nor the consumption figures indicated in the invitation to tender. The final order quantities may be higher or lower than stated.
The subject matter and requirements of the procurement are described in detail in the invitation to tender and its annexes.
1️⃣
Sisäinen tunniste: 1.-0
Otsikko: Seeds and needles separately, activity 0.1 mCi
Tämä hankinta soveltuu myös pienille ja keskisuurille yrityksille (pk-yrityksille) ✅
Hankinnan kuvaus: Lot is described in more detail in Annex 1 Product and Price Form.
Edistettävä sosiaalinen tavoite: Ihmisoikeuksia koskeva due diligence -velvoite maailmanlaajuisissa toimitusketjuissa
Maa: Suomi 🇫🇮
Kesto: 48 kuukautta Myöntämisperusteet
Hinta ✅ Otsikko
Erän tunnistenumero: LOT-0001
2️⃣
Sisäinen tunniste: 2.-1
Otsikko: Seeds and needles separately, activity 0.2 mCi
Otsikko
Erän tunnistenumero: LOT-0002
3️⃣
Sisäinen tunniste: 3.-2
Otsikko: Seeds preloaded in the needle, activity 0.1 mCi
Otsikko
Erän tunnistenumero: LOT-0003
4️⃣
Sisäinen tunniste: 4.-3
Otsikko: Seeds preloaded in the needle, activity 0.2 mCi
Hankinnan kuvaus: Lot is described in more detail in Annex 1 Product and Price Form
Otsikko
Erän tunnistenumero: LOT-0004
Menettely Toimenpiteen tyyppi
Avoin menettely ✅
Oikeusperusta: Direktiivi 2014/24/EU
Menettelyn tärkeimmät piirteet:
The procurement shall comply with the Act on Public Procurement and Concession Contracts (1397/2016, referred to as the Public Procurement Act). The procurement value exceeds the EU threshold value. The procedure shall be an open procedure as defined in section 32 of the Public Procurement Act.
PROCESSING OF TENDERS
The procedure shall include the following phases:
Contracting entity
1. Opens the tenders
2. Verifies the suitability of the tenderer
3. Checks that the tenders conform to the invitation to tender
4. Conducts possible trial use
5. Compares the tenders
6. Makes a procurement decision and communicates it to all the tenderers
7. Requests and checks certificates and reports on the suitability of the winning tenderer(s)
8. Concludes an agreement with the selected tenderer(s)
LANGUAGE OF THE COMPETITIVE TENDERING PROCEDURE
The procurement documents are available in English. If a tenderer needs the documents in another language, the tenderer shall be responsible for translation and liable for the associated costs. Tenders must be prepared in English.
PARALLEL TENDERS
Parallel tenders are not permitted.
The procurement shall comply with the Act on Public Procurement and Concession Contracts (1397/2016, referred to as the Public Procurement Act). The procurement value exceeds the EU threshold value. The procedure shall be an open procedure as defined in section 32 of the Public Procurement Act.
PROCESSING OF TENDERS
The procedure shall include the following phases:
Contracting entity
1. Opens the tenders
2. Verifies the suitability of the tenderer
3. Checks that the tenders conform to the invitation to tender
4. Conducts possible trial use
5. Compares the tenders
6. Makes a procurement decision and communicates it to all the tenderers
7. Requests and checks certificates and reports on the suitability of the winning tenderer(s)
8. Concludes an agreement with the selected tenderer(s)
LANGUAGE OF THE COMPETITIVE TENDERING PROCEDURE
The procurement documents are available in English. If a tenderer needs the documents in another language, the tenderer shall be responsible for translation and liable for the associated costs. Tenders must be prepared in English.
PARALLEL TENDERS
Parallel tenders are not permitted.
Hallinnolliset tiedot
Tarjousten tai osallistumishakemusten vastaanottamisen määräaika: 2026-03-09 10:00:00 📅
Tarjousten avaamista koskevat ehdot: 2026-03-09 10:15:00 📅
Kielet, joilla tarjoukset tai osallistumishakemukset voidaan jättää: englanti 🗣️
Vähimmäisaika, jonka kuluessa tarjoajan on pidettävä tarjous voimassa: 9 kuukautta Tarjouspyynnön ehdot
Tarjoaja voi jättää useamman kuin yhden tarjouksen
Tarjousten avaamisen päivämäärä: 2026-03-09 10:15:00 📅
Sähköinen laskutus: Pakollinen
Sähköistä tilaamista käytetään ✅
Sähköistä maksua käytetään ✅
Lisätietojen pyytämisen määräaika: 2026-02-17 10:00:00 📅
Täydentävät tiedot Arvostelurunko
Nimi: Markkinaoikeus
Kansallinen rekisterinumero: 3006157-6
Postiosoite: Radanrakentajantie 5
Postinumero: 00520
Postitoimipaikka: Helsinki
Alue: Helsinki-Uusimaa
🏙️
Maa: Suomi 🇫🇮
Sähköposti: markkinaoikeus@oikeus.fi📧
Puhelin: +358 295643300📞
URL: http://www.oikeus.fi/markkinaoikeus🌏 Palvelu, josta voi saada tietoja uudelleentarkastelumenettelystä Sama kuin: Nimi ja osoitteet Uudelleentarkastelumenettely
Tarkat tiedot uudelleentarkastelumenettelyjen määräajasta (määräajoista):
Precise information about the deadlines for the appeal procedure will be provided in the procurement decision.
Ilmoitus tehdystä sopimuksesta (2026-09-23) Kohde Hankinnan laajuus
Hankinnan kokonaisarvo (ilman arvonlisäveroa): 1 100 000 EUR 💰
Kuvaus
Sisäinen tunniste: HUS 365-2025
Hankinnan kuvaus:
The HUS Group requests tenders for radioactive seeds for localizing breast cancer. The procurement includes the products that are described in more detail in Annex 1 Product and Price Form. The tenderer must enter the product details and offered prices in Annex 1 Product and Price Form.
The procurement is divided into lots, as follows:
1. Seeds and needles separately, activity 0.1 mCi 2. Seeds and needles separately, activity 0.2 mCi 3. Seeds preloaded in the needle, activity 0.1 mCi 4. Seeds preloaded in the needle, activity 0.2 mCi The tenderers may leave a tender to one or more lots as they decide.
The goal of this competitive procurement is to get products that are safe to use and serve the intended purpose. The goal is also to have good product delivery reliability and to have products available when they are needed.
The subject matter of the procurement also includes additional products related to the products tendered, such as additional sizes and accessories, which are indicated in Annex 1 Product and Price Form. In addition, during the contract period, products belonging to the product groups that are the subject of the contract, may be acquired in accordance with the estimated value of the contract, also when they are not specified in the product annex (please see draft agreement).
The agreement period is two (2) years. It may be extended by an option period of 1 + 1 years.
The total estimated value of the procurement (VAT 0%) is approximately EUR 900 000 -1 100 000. This is an estimate and the contracting entity does not commit neither to the stated euro amounts and nor the consumption figures indicated in the invitation to tender. The final order quantities may be higher or lower than stated.
The subject matter and requirements of the procurement are described in detail in the invitation to tender and its annexes.
The HUS Group requests tenders for radioactive seeds for localizing breast cancer. The procurement includes the products that are described in more detail in Annex 1 Product and Price Form. The tenderer must enter the product details and offered prices in Annex 1 Product and Price Form.
The procurement is divided into lots, as follows:
1. Seeds and needles separately, activity 0.1 mCi 2. Seeds and needles separately, activity 0.2 mCi 3. Seeds preloaded in the needle, activity 0.1 mCi 4. Seeds preloaded in the needle, activity 0.2 mCi The tenderers may leave a tender to one or more lots as they decide.
The goal of this competitive procurement is to get products that are safe to use and serve the intended purpose. The goal is also to have good product delivery reliability and to have products available when they are needed.
The subject matter of the procurement also includes additional products related to the products tendered, such as additional sizes and accessories, which are indicated in Annex 1 Product and Price Form. In addition, during the contract period, products belonging to the product groups that are the subject of the contract, may be acquired in accordance with the estimated value of the contract, also when they are not specified in the product annex (please see draft agreement).
The agreement period is two (2) years. It may be extended by an option period of 1 + 1 years.
The total estimated value of the procurement (VAT 0%) is approximately EUR 900 000 -1 100 000. This is an estimate and the contracting entity does not commit neither to the stated euro amounts and nor the consumption figures indicated in the invitation to tender. The final order quantities may be higher or lower than stated.
The subject matter and requirements of the procurement are described in detail in the invitation to tender and its annexes.
Lisätietoja:
Due to technical challenges with the form, it has been noted on the form that the procurement has not been divided into parts. However, the procurement has been divided into parts as follows.
The procurement is divided into lots, as follows:
1. Seeds and needles separately, activity 0.1 mCi 2. Seeds and needles separately, activity 0.2 mCi 3. Seeds preloaded in the needle, activity 0.1 mCi 4. Seeds preloaded in the needle, activity 0.2 mCi
Due to technical challenges with the form, it has been noted on the form that the procurement has not been divided into parts. However, the procurement has been divided into parts as follows.
The procurement is divided into lots, as follows:
1. Seeds and needles separately, activity 0.1 mCi 2. Seeds and needles separately, activity 0.2 mCi 3. Seeds preloaded in the needle, activity 0.1 mCi 4. Seeds preloaded in the needle, activity 0.2 mCi
Kesto
Aloituspäivä: 2026-05-27 📅
Myöntämisperusteet
Hinta (painotus): 100
Otsikko
Erän tunnistenumero: LOT-0000
Sopimuksen tekeminen
Sopimus/erä myönnetään ✅
Erän tunnistenumero: LOT-0000
Sopimuksen numero: HUS 365-2025 Radioactive seeds for localizing breast cancer_BXTAccelyon Ltd
Sopimuksen tekopäivä: 2026-05-18 📅
Tietoa tarjouskilpailuista
Saatujen tarjousten määrä: 3
Tiedot sopimuksen/erän arvosta (ilman alv:tä)
Sopimuksen/osuuden kokonaisarvo: 550 000 EUR 💰
Tarjouksen tunniste: HUS 365-2025 / Radioactive seeds for localizing breast cancer 4708617_MoMedico ApS
Osan tai osien ryhmän tunniste: LOT-0000 Toimeksisaajan nimi ja osoite
Nimi: BXTAccelyon Ltd
Kansallinen rekisterinumero: 08252168
Postinumero: SL1 8DF
Postitoimipaikka: Burnham
Maa: Iso-Britannia 🇬🇧
Puhelin: 0447881029140📞
Organisaation koko: Mikro, pieni tai keskisuuri
Tarjouksen tunniste: BXTAccelyon Ltd 4711656
Nimi: MoMedico ApS
Kansallinen rekisterinumero: DK32324304
Postinumero: 2840
Postitoimipaikka: Holte
Alue: Byen København
🏙️
Maa: Tanska 🇩🇰
Täydentävät tiedot Lisätietoja
Due to technical challenges with the form, it has been noted on the form that the procurement has not been divided into parts. However, the procurement has been divided into parts as follows.
The procurement is divided into lots, as follows:
1. Seeds and needles separately, activity 0.1 mCi 2. Seeds and needles separately, activity 0.2 mCi 3. Seeds preloaded in the needle, activity 0.1 mCi 4. Seeds preloaded in the needle, activity 0.2 mCi
Due to technical challenges with the form, it has been noted on the form that the procurement has not been divided into parts. However, the procurement has been divided into parts as follows.
The procurement is divided into lots, as follows:
1. Seeds and needles separately, activity 0.1 mCi 2. Seeds and needles separately, activity 0.2 mCi 3. Seeds preloaded in the needle, activity 0.1 mCi 4. Seeds preloaded in the needle, activity 0.2 mCi
Uudelleentarkastelumenettely
Tarkat tiedot uudelleentarkastelumenettelyjen määräajasta (määräajoista):
Jollei toisin säädetä, valitus tai hankintaoikaisuvaatimus on tehtävä kirjallisesti 14 päivän kuluessa siitä, kun asianosainen on saanut tiedon hankintaa koskevasta päätöksestä valitusosoituksineen.